Furthermore, if drugs that upregulate the RPL11 expression and enhance the function of the nucleolar stress response are identified, therapeutic strategies for overcoming multidrug resistance in pediatric BCP-ALL can be developed. This evidence concerns the gene RPL11 and acute lymphoblastic leukemia.